logo
Baby born with rare life-threatening disorder makes medical history

Baby born with rare life-threatening disorder makes medical history

Independent16-05-2025
A baby born with a rare, life-threatening genetic disorder is thriving after receiving a groundbreaking, personalized gene-editing treatment.
The experimental therapy, crafted specifically for his condition, corrected a minute yet crucial error in his genetic code, offering hope for others with similarly rare diseases.
The infant, KJ Muldoon of Clifton Heights, Pennsylvania, was diagnosed shortly after birth with severe CPS1 deficiency.
This condition, estimated to affect roughly one in a million babies, prevents the body from effectively removing ammonia, leading to potentially toxic buildup in the bloodstream.
While liver transplants can be a solution for some, this innovative gene-editing treatment offers a new avenue of hope.
The study, published in the New England Journal of Medicine, details KJ's case and highlights the potential of this technology.
Dr. Kiran Musunuru, a University of Pennsylvania gene editing expert and study co-author, hailed the treatment as "the first step towards the use of gene editing therapies to treat a wide variety of rare genetic disorders for which there are currently no definitive medical treatments."
KJ's case represents a significant advancement in personalized medicine, demonstrating the potential to tailor treatments to individual genetic profiles.
While widespread availability of such personalized therapies remains on the horizon, this success story offers a beacon of hope for the millions affected by rare genetic conditions often overlooked by mainstream medical advancements.
KJ is among the first to benefit from this cutting-edge approach, paving the way for future applications of gene editing in treating a broader spectrum of rare diseases.
Knowing KJ's odds, parents Kyle and Nicole Muldoon, both 34, worried they could lose him.
'We were, like, you know, weighing all the options, asking all the questions for either the liver transplant, which is invasive, or something that's never been done before,' Nicole said.
'We prayed, we talked to people, we gathered information, and we eventually decided that this was the way we were going to go,' her husband added.
Within six months, the team at Children's Hospital of Philadelphia and Penn Medicine, along with their partners, created a therapy designed to correct KJ's faulty gene. They used CRISPR, the gene editing tool that won its inventors the Nobel Prize in 2020. Instead of cutting the DNA strand like the first CRISPR approaches, doctors employed a technique that flips the mutated DNA 'letter' — also known as a base — to the correct type. Known as 'base editing," it reduces the risk of unintended genetic changes.
It's 'very exciting' that the team created the therapy so quickly, said gene therapy researcher Senthil Bhoopalan at St. Jude Children's Research Hospital in Memphis, who wasn't involved in the study. 'This really sets the pace and the benchmark for such approaches.'
In February, KJ got his first IV infusion with the gene editing therapy, delivered through tiny fatty droplets called lipid nanoparticles that are taken up by liver cells.
While the room was abuzz with excitement that day, 'he slept through the entire thing,' recalled study author Dr. Rebecca Ahrens-Nicklas, a gene therapy expert at CHOP.
After follow-up doses in March and April, KJ has been able to eat more normally and has recovered well from illnesses like colds, which can strain the body and exacerbate symptoms of CPS1. The 9 ½-month old also takes less medication.
Considering his poor prognosis earlier, 'any time we see even the smallest milestone that he's meeting – like a little wave or rolling over – that's a big moment for us,' his mother said.
Still, researchers caution that it's only been a few months. They'll need to watch him for years.
'We're still very much in the early stages of understanding what this medication may have done for KJ,' Ahrens-Nicklas said. 'But every day, he's showing us signs that he's growing and thriving.'
Researchers hope what they learn from KJ will help other rare disease patients.
Gene therapies, which can be extremely expensive to develop, generally target more common disorders in part for simple financial reasons: more patients mean potentially more sales, which can help pay the development costs and generate more profit. The first CRISPR therapy approved by the U.S. Food and Drug Administration, for example, treats sickle cell disease, a painful blood disorder affecting millions worldwide.
Musunuru said his team's work — funded in part by the National Institutes of Health — showed that creating a custom treatment doesn't have to be prohibitively expensive. The cost was 'not far off' from the $800,000-plus for an average liver transplant and related care, he said.
'As we get better and better at making these therapies and shorten the time frame even more, economies of scale will kick in and I would expect the costs to come down,' Musunuru said.
Scientists also won't have to redo all the initial work every time they create a customized therapy, Bhoopalan said, so this research 'sets the stage' for treating other rare conditions.
Carlos Moraes, a neurology professor at the University of Miami who wasn't involved with the study, said research like this opens the door to more advances.
'Once someone comes with a breakthrough like this, it will take no time" for other teams to apply the lessons and move forward, he said. 'There are barriers, but I predict that they are going to be crossed in the next five to 10 years. Then the whole field will move as a block because we're pretty much ready.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

RFK Jr. looks to boot panel that decided which HIV and cancer screenings would be free: report
RFK Jr. looks to boot panel that decided which HIV and cancer screenings would be free: report

The Independent

time11 minutes ago

  • The Independent

RFK Jr. looks to boot panel that decided which HIV and cancer screenings would be free: report

Health and Human Services Secretary Robert F. Kennedy Jr. is reportedly planning to remove all the members of an influential health task force that helps determine what preventative care services insurers must cover for free, after removing all members of a vaccine advisory board last month. Kennedy wants to clean house at U.S. Preventative Services Task Force next because he believes its 16 members have become too 'woke,' The Wall Street Journal reports. Under 2010's Affordable Care Act, the task force makes evidence-based, public recommendations on a variety of treatments, ranging HIV prevention to prenatal care to mental health, that insurers must cover at no cost to patients. Health and Human Services has said the secretary hasn't made a final decision regarding the task force. The Independent has contacted the agency for comment. Kennedy's reported dissatisfaction with the group comes after the American Conservative magazine accused the task force of being a 'festering corner of woke bureaucracy' in an article earlier this month. 'The task force is packed with Biden administration appointees devoted to the ideological capture of medicine,' the author argued, pointing to 'sinister' recent task force actions committing to removing racial inequities in health care and using more inclusive language around gender. Earlier this month, a July meeting of the task force was postponed. At the time, a letter from over 100 health organizations warned about the politicization of the task force's work. 'The loss of trustworthiness in the rigorous and nonpartisan work of the Task Force would devastate patients, hospital systems, and payers as misinformation creates barriers to accessing lifesaving and cost effective care,' the letter reads. 'When something works well and helps inform doctors about how to take care of their patients, to postpone the task force's work just doesn't make any sense,' Dr. Bobby Mukkamala, president of the American Medical Association, told The New York Times after the meeting was postponed. 'This flies in the face of what is good for the country's health.' In June, the Supreme Court upheld the task force's ability to recommend free coverage for preventative services, in the face of a challenge from individuals and businesses objecting to the body's recommendation regarding HIV prevention medication. Concern over the fate of the task force comes after Kennedy removed all the members of a vaccine advisory board, replacing them with some members who share the secretary's vaccine skepticism.

Company involved in Coldplay KissCam drama hires Gwyneth Paltrow as spokesperson
Company involved in Coldplay KissCam drama hires Gwyneth Paltrow as spokesperson

The Independent

timean hour ago

  • The Independent

Company involved in Coldplay KissCam drama hires Gwyneth Paltrow as spokesperson

Astronomer — the company whose CEO resigned after being caught on a KissCam at a Coldplay rock concert embracing a woman who was not his wife — is trying to move on from the drama with someone who knows the band pretty well. Actress Gwyneth Paltrow, who was married to Coldplay's frontman Chris Martin for 13 years, announced Friday on X that she has been hired by Astronomer as a spokesperson. Astronomer, a tech company based in New York, found itself in an uncomfortable spotlight when two of its executives were caught on camera in an intimate embrace at a Coldplay concert — a moment that was then flashed on a giant screen in the stadium. CEO Andy Byron and human resource executive Kristin Cabot were caught by surprise when Martin asked the cameras to scan the crowd during a concert earlier this month. 'Either they're having an affair or they're just very shy,' Martin joked when the couple appeared on screen and quickly tried to hide their faces. In a short video, the 'Shakespeare in Love' and 'Ironman' star said she had been hired as a 'very temporary' spokesperson for Astronomer. 'Astronomer has gotten a lot of questions over the last few days and they wanted me to answer the most common ones,' Paltrow said, smiling and deftly avoiding mention of the KissCam fuss. 'We've been thrilled that so many people have a newfound interest in data workflow automation,' she said. 'We will now be returning to what we do best — delivering game-changing results for our customers.' When footage from the KissCam first spread online, it wasn't immediately clear who the couple were. Soon after the company identified the pair, and Byron resigned followed by Cabot. The video clip resulted in a steady stream of memes, parody videos and screenshots of the pair's shocked faces filling social media feeds. Online streams of Coldplay's songs jumped 20% in the days after the video went viral, according to Luminate, an industry data and analytics company.

Ben Askren reveals devastating impact of double lung transplant in heartbreaking new health update
Ben Askren reveals devastating impact of double lung transplant in heartbreaking new health update

Daily Mail​

timean hour ago

  • Daily Mail​

Ben Askren reveals devastating impact of double lung transplant in heartbreaking new health update

Ben Askren has revealed the incredible toll his health episode has taken on him in a new social media post on Saturday. UFC cult hero Askren, regarded as one of the world's top lightweight fighters during the peak of his career, has been the subject of widespread concern among the MMA community after being hospitalised with pneumonia. Askren, 41, required a double lung transplant to save his life and returned home from hospital this week. He has been told by doctors that he s fully capable of living a lengthy, healthy life. But for now, the American former wrestler has a long journey to a full recovery, revealing on Instagram that he struggles to lift a five-pound dumbbell, such is his lack of strength post health crisis. 'I've been home for four days now,' he began. 'It's awesome. I get to sleep in my own bed, eat my own food, hang out with my family, it's great. 'That being said, I've still got so many physical challenges to deal with. I'm still down abot 35 pounds from where I should be. I can't walk. This five-pound weight, it's actually hard for me to curl. 'Right before I had to go to the hospital I was feeling strong, I was able to curl 45 pounds. I was out doing hill sprints.' However, Askren, who struggled to speak at certain points of video and had to catch his breath, is determined to improve his condition. 'I am where I am now,' he said. 'But I know I'll be somewhere different in a month.' Askren previously revealed that he had died four times before his life-saving transplant. 'So, I only died four times. The ticker stopped for about 20 seconds,' he said. 'But, I got the double lung transplant and made it out to the other side of it. I was actually 147lbs. I haven't been 147lbs since 15-years-old. 'The thing that was most impactful to me was the love I felt from everybody. It was almost like I got to have my own funeral. 'The outpouring of love from the wrestling community was just amazing. It felt so good. So I'm more motivated than ever to get back and do what I can to help out. 'I love you guys and I appreciate you guys. This has been tough. Not only on me but on my whole family and community. 'I hope you guys appreciate the update and sometime down the road maybe Amy and I can detail everything a little more'. More to follow. View this post on Instagram A post shared by Ben Askren (@benaskren)

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store